Sana Biotechnology, Inc. (SANA) Operating cash flow 2019–2025
Sana Biotechnology, Inc. (SANA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$143.8MFY2025 · since FY2019: -$85.5M → -$143.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$143.8M | +35.5% |
| FY2024 | -$223.2M | +12.0% |
| FY2023 | -$253.6M | +12.6% |
| FY2022 | -$290.1M | -15.5% |
| FY2021 | -$251.1M | -81.9% |
| FY2020 | -$138.0M | -61.3% |
| FY2019 | -$85.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice